Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293111
Status:
TERMINATED
Last Update Posted:
2014-05-12
First Post:
2006-02-16
Brief Title:
Safety and Efficacy of SDX-101 R-Etodolac in Patients With Relapsed or Refractory Multiple Myeloma MM
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc